Results 21 to 30 of about 577 (113)

Cáncer de esófago

open access: yesCirugía del Uruguay, 2020
Presentado en sesión de 4 de octubre de ...
Pedro Larghero Ibarz
doaj   +2 more sources

Impact of co‐morbidities on health‐related quality of life 10 years after surgical treatment of oesophageal cancer

open access: yesBJS Open, Volume 4, Issue 4, Page 601-604, August 2020., 2020
This study investigated the impact of co‐morbidities on health‐related quality of life during long‐term follow‐up after oesophagectomy. The results showed that the substantial impact of co‐morbidities on reported general health might be associated with symptoms and health‐related quality of life 10 years after oesophageal cancer treatment.
F. Klevebro, A. Johar, P. Lagergren
wiley   +1 more source

Machine learning to predict early recurrence after oesophageal cancer surgery

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 8, Page 1042-1052, July 2020., 2020
Early recurrence after surgery for adenocarcinoma of the oesophagus is common. A risk prediction model was derived using modern machine learning methods that accurately predicts risk of early recurrence using postoperative pathology. Machine learning may help Background Early cancer recurrence after oesophagectomy is a common problem, with an incidence
S. A. Rahman   +87 more
wiley   +1 more source

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 8, Page 1053-1061, July 2020., 2020
Conditional survival accounts for the time already survived after surgery and may be of additional informative value. A nomogram was constructed that predicts 5‐year survival of patients with oesophageal cancer after neoadjuvant treatment followed by surgery, based on cardiac co‐morbidity, cN category, ypTN stage, chyle leakage and pulmonary ...
E. R. C. Hagens   +6 more
wiley   +1 more source

Impact of postoperative complications on survival after oesophagectomy for oesophageal cancer

open access: yesBJS Open, Volume 4, Issue 3, Page 405-415, June 2020., 2020
Recent evidence suggests that complications following oesophagectomy may decrease short‐ and long‐term survival. In this study, Clavien–Dindo grade II and IV complications decreased overall and recurrence‐free survival in univariable and multivariable Cox regression analyses.
J. R. Bundred   +5 more
wiley   +1 more source

Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery

open access: yesBJS Open, Volume 4, Issue 3, Page 424-431, June 2020., 2020
A nationwide prospective register‐based study examined the extent of lymphadenectomy in curative gastric cancer surgery and its effects on long‐term survival. More evidence in favour of thorough lymphadenectomy Background Gastrectomy including D2 lymphadenectomy is regarded as the standard curative treatment for advanced gastric cancer in Asia.
C.‐H. Kung   +5 more
wiley   +1 more source

Tratamiento quirúrgico del Cáncer de Esófago

open access: yesRevista de la Facultad de Medicina Humana, 2016
Se presentan los resultados de un estudio realizado en el Servicio de Cirugía del Hospital Edgardo Rebagliati, ESSALUD; correspondiente al manejo quirúrgico del cáncer epidermoide y glandular de esófago y unión esofagogástrica con infiltración distal ...
Manuel Huamán Guerrero
doaj   +1 more source

Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma

open access: yesBJS Open, Volume 4, Issue 3, Page 416-423, June 2020., 2020
The neutrophil to lymphocyte ratio, dichotomized at 2·25, was strongly associated with Mandard tumour regression grade in patients who had neoadjuvant chemotherapy for oesophageal adenocarcinoma. The systemic inflammatory response may offer a novel therapeutic target for patients at risk of poor response.
A. G. M. T. Powell   +6 more
wiley   +1 more source

UEG Week 2021 Moderated Posters

open access: yes, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 163-259, October 2021.
wiley   +1 more source

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study

open access: yesBJS Open, Volume 4, Issue 1, Page 59-70, February 2020., 2020
After oesophagectomy for oesophageal adenocarcinoma (OAC), the 5‐year survival rate is currently only 30 per cent. There is strong observational evidence that statin use is associated with reduced all‐cause and cancer‐specific mortality in patients with OAC.
L. Alexandre   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy